1. Home
  2. AGPU vs RDHL Comparison

AGPU vs RDHL Comparison

Compare AGPU & RDHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

AGPU

Axe Compute Inc. Common Stock

N/A

Current Price

$1.88

Market Cap

6.9M

Sector

N/A

ML Signal

N/A

Logo Redhill Biopharma Ltd.

RDHL

Redhill Biopharma Ltd.

HOLD

Current Price

$0.95

Market Cap

5.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AGPU
RDHL
Founded
2002
2009
Country
United States
Israel
Employees
24
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.9M
5.6M
IPO Year
N/A
2012

Fundamental Metrics

Financial Performance
Metric
AGPU
RDHL
Price
$1.88
$0.95
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
67.7K
34.6K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$486.27
$381.91
Revenue Next Year
$65.50
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.00
$0.91
52 Week High
$9.00
$3.60

Technical Indicators

Market Signals
Indicator
AGPU
RDHL
Relative Strength Index (RSI) 31.98 37.34
Support Level N/A $0.91
Resistance Level $2.51 $1.45
Average True Range (ATR) 0.32 0.07
MACD 0.09 -0.00
Stochastic Oscillator 1.66 10.45

Price Performance

Historical Comparison
AGPU
RDHL

About AGPU Axe Compute Inc. Common Stock

Axe Compute Inc functions as an active infrastructure operator. The company intends to expand access to AI compute resources by utilizing the Aethir network, which provides scalable, cost-efficient cloud GPU services for AI, machine learning, gaming, and rendering applications. Through the use of Aethir's decentralized international infrastructure, it aims to provide access to bare-metal GPUs at scale for both emerging and established organizations. It plans to monetize access to the network by serving enterprise customers that require guaranteed capacity, service-level agreements, and a counterparty operating within conventional corporate and regulatory frameworks.

About RDHL Redhill Biopharma Ltd.

Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.

Share on Social Networks: